ScholarLens Back to search
2013•Journal of Molecular Diagnostics and TherapyRequires access

Advances in the relationship between the detection of glypican-3 in serum and the diagnosis of primary hepatic carcinoma

Juanping Yu, Da An

Open publisher page 1 citations

Abstract

Glypican-3(GPC3) was confirmed to be a novel tumor marker for hepatocellular carcinoma(HCC) besides alpha-fetoprotein(AFP). With the constant deepening of GPC3 research, it was found not only in tissues of patients with HCC but also in the serum. In the diagnosis of HCC, there were higher sensitivity and specificity, especially in the early stage, which had great value in clinical application, and bring new hope for the diagnosis of HCC.

About this research paper

What this paper is about

Glypican-3(GPC3) was confirmed to be a novel tumor marker for hepatocellular carcinoma(HCC) besides alpha-fetoprotein(AFP). With the constant deepening of GPC3 research, it was found not only in tissues of patients with HCC but also in the serum. In the diagnosis of HCC, there were higher sensitivity and specificity, especially in the early stage, which had great value in clinical application, and bring new hope for the diagnosis of HCC.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Glypican-3(GPC3) was confirmed to be a novel tumor marker for hepatocellular carcinoma(HCC) besides alpha-fetoprotein(AFP). With the constant deepening of GPC3 research, it was found not only in tissues of patients with HCC but also in the serum. In the diagnosis of HCC, there were higher sensitivity and specificity, especially in the early stage, which had great value in clinical application, and bring new hope for the diagnosis of HCC.

Key concepts: Glypican 3, Hepatocellular carcinoma, Internal medicine, Alpha-fetoprotein, Tumor marker, Medicine, Stage (stratigraphy), Gastroenterology

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
Advances in the relationship between the detection of glypican-3 in serum and the diagnosis of primary hepatic carcinoma — Research Paper | ScholarLens